Oncolytics Biotech Inc.

1.00 USD
-0.02 (-1.96%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Oncolytics Biotech Inc. stock is down -9.91% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 17.39% of the previous 22 June’s closed higher than May.

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc. focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent. The company was incorporated in 1998 and is headquartered in Calgary, Canada.